ArticleHGG advances2026
Paternal age effect in autosomal dominant or X-linked de novo variants identified by genome-wide sequencing.
Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An increased frequency of sporadic autosomal dominant disorders has been observed among children born to older fathers. This paternal age effect is thought to reflect an accumulation of new mutations in the male germ line as DNA replication and cell division continue to occur as men age. Genome-wide sequencing is useful for identifying disease-causing genetic variants in patients with suspected genetic diseases and for determining inheritance or de novo mutation of the variants when done in patient-parent trios. We analyzed paternal ages in 593 families who received trio or quad exome or genome sequencing for suspected genetic disease. The mean age of fathers of children with de novo disease-causing variants (35.09 years) was significantly greater than that of children with inherited disease-causing variants (33.78 years, p = 0.04). The mean age of mothers of children with de novo disease-causing variants (31.86 years) was not significantly greater than that of children with inherited disease-causing variants (30.80 years, p = 0.09). Interestingly, when the de novo disease-causing variants were broken down into subgroups by variant type, both mean paternal age and mean maternal age of children with de novo indel variants (paternal = 36.33 years, maternal = 33.34 years) were significantly higher than in children identified to have de novo single-nucleotide variants (paternal = 34.35 years, p = 0.03; maternal = 31.15 years, p = 0.004). This observation, which may have implications for how indels arise, requires further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.